Elliott D Crouser

Ohio State University

NIH Rank #7125
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#7,125
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 4 grants · National rank #7125.

Top grants by award amount

Elliott D Crouser's NIH grant portfolio, ranked by award amount.

  • 5R01HL162955-02R01
    Molecular Characterization of Progressive Pulmonary Sarcoidosis
    $772.7K
    award amount
  • 5U01AI167784-03U01
    Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
    $494.2K
    award amount
  • 5R21AI168804-02R21
    Role of Renin-Angiotensin-Aldosterone System during sarcoidosis granuloma formation
    $236.3K
    award amount
  • 1R21AI180862-01A1R21
    Redox Regulation of Sarcoidosis Granulomas and Fibrosis
    $196.9K
    award amount

Affiliations

Institutions that have administered grants for Elliott D Crouser.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Ohio State University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7125
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions